U.S. Pharmacopeial Convention Signs Pact With Chinese Regulators To Strengthen Cooperation
This article was originally published in PharmAsia News
Executive Summary
BEIJING - In the latest advance in a two-year drive to step up cooperation with Chinese scientists and regulators - during a series of drug and food adulteration scandals that have claimed casualties across the Pacific - the U.S. Pharmacopeial Convention has signed a new agreement with China's Center for Disease Control and Prevention